NeoGenomics to Provide MDx Testing to Aurora Diagnostics | GenomeWeb

NEW YORK (GenomeWeb) – Cancer genetics testing firm NeoGenomics today announced Aurora Diagnostics has selected it to be the primary partner for molecular testing in Aurora's US network of specialized pathology laboratories.

Aurora will be able to standardize oncology molecular testing services across its 19 labs as a result of the deal, NeoGenomics said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.